PHARMANOUNOU: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMANOUNOU
Largest movements
- Cash -€18,735
down €18,735 (-24.3%), from €77,010 to €58,275
mainly Contributions, distributions and other (-€30,245) and Investment in fixed assets (net) (-€6,914)
- Receivables within one year +€2,970
up €2,970 (+40.6%), from €7,320 to €10,289
- Profit (loss) carried forward -€8,820
down €8,820 (-14.8%), from €59,611 to €50,791
- Debts after one year -€5,248
down €5,248 (-79.8%), from €6,572 to €1,325
- Tax, wage and social debts -€1,321
down €1,321 (-6.8%), from €19,354 to €18,033
of which Taxes: -€1,321
- Gross operating margin -€701
down €701 (-1.9%), from €36,187 to €35,487
- Depreciation +€664
up €664 (+11.2%), from €5,907 to €6,571
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €96,351 | €81,052 | -€15,299 | -15.9% |
| Fixed assets | 21/28 | €12,022 | €12,365 | +€343 | +2.9% |
| Tangible fixed assets | 22/27 | €12,022 | €12,365 | +€343 | +2.9% |
| Furniture and vehicles | 24 | €12,022 | €7,564 | -€4,457 | -37.1% |
| Other tangible fixed assets | 26 | - | €4,801 | +€4,801 | |
| Current assets | 29/58 | €84,330 | €68,688 | -€15,642 | -18.5% |
| Amounts receivable within one year | 40/41 | €7,320 | €10,289 | +€2,970 | +40.6% |
| Trade receivables | 40 | €7,320 | €10,289 | +€2,970 | +40.6% |
| Cash at bank and in hand | 54/58 | €77,010 | €58,275 | -€18,735 | -24.3% |
| Deferred charges and accrued income | 490/1 | - | €123 | +€123 | |
| Total equity and liabilities | 10/49 | €96,351 | €81,052 | -€15,299 | -15.9% |
| Equity | 10/15 | €61,611 | €52,791 | -€8,820 | -14.3% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €59,611 | €50,791 | -€8,820 | -14.8% |
| Amounts payable | 17/49 | €34,740 | €28,262 | -€6,479 | -18.6% |
| Amounts payable after more than one year | 17 | €6,572 | €1,325 | -€5,248 | -79.8% |
| Financial debts | 170/4 | €6,572 | €1,325 | -€5,248 | -79.8% |
| Amounts payable within one year | 42/48 | €28,168 | €26,937 | -€1,231 | -4.4% |
| Current portion of amounts payable after more than one year | 42 | €5,164 | €5,248 | +€83 | +1.6% |
| Trade debts | 44 | €272 | €627 | +€355 | +130.5% |
| Suppliers | 440/4 | €272 | €627 | +€355 | +130.5% |
| Taxes, remuneration and social security | 45 | €19,354 | €18,033 | -€1,321 | -6.8% |
| Taxes | 450/3 | €17,554 | €16,233 | -€1,321 | -7.5% |
| Remuneration and social security | 454/9 | €1,800 | €1,800 | = | 0.0% |
| Other amounts payable | 47/48 | €3,378 | €3,030 | -€348 | -10.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,907 | €6,571 | +€664 | +11.2% |
| Other operating charges | 640/8 | €220 | - | -€220 | |
| Gross operating margin | 9900 | €36,187 | €35,487 | -€701 | -1.9% |
| Operating profit (loss) | 9901 | €30,060 | €28,916 | -€1,144 | -3.8% |
| Financial charges | 65/66B | €354 | €380 | +€26 | +7.4% |
| Recurring financial charges | 65 | €354 | €380 | +€26 | +7.4% |
| Profit (loss) for the period before taxes | 9903 | €29,706 | €28,535 | -€1,170 | -3.9% |
| Income taxes | 67/77 | €7,083 | €7,111 | +€28 | +0.4% |
| Profit (loss) for the period | 9904 | €22,623 | €21,425 | -€1,199 | -5.3% |
| Profit (loss) for the period to be appropriated | 9905 | €22,623 | €21,425 | -€1,199 | -5.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.